Ohio Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 32 (63% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 15,703
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 25.04%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 5,709
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 26.59%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 69.64% 68.77%
White, Hispanic/Latino Patients 3.76% 4.01%
Black/African American, Non-Hispanic/Latino Patients 12.97% 13.50%
Black/African American, Hispanic/Latino Patients 0.34% 0.35%
Asian Patients3 0.92% 0.98%
American Indian/Alaska Native Patients3 0.18% 0.16%
Native Hawaiian/Other Pacific Islander Patients3 0.25% 0.32%
Patients with More Than One Race3 2.20% 2.24%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.64% 3.35%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.55% 0.79%
Unreported/Refused to Report Race and Ethnicity 6.56% 5.54%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,591
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 46.61%
COVID-19 Immunization Series Completed 1,270
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 43.90%
COVID-19 Immunization Series Additional 3,636
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 36.75%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 49.47% 53.23% 60.07%
White, Hispanic/Latino Patients 8.67% 8.35% 6.19%
Black/African American, Non-Hispanic/Latino Patients 20.43% 21.10% 16.83%
Black/African American, Hispanic/Latino Patients 1.13% 0.39% 0.41%
Asian Patients3 2.33% 3.15% 3.36%
American Indian/Alaska Native Patients3 0.06% 0.16% 3.85%
Native Hawaiian/Other Pacific Islander Patients3 0.44% 0.47% 0.14%
Patients with More Than One Race3 3.46% 3.23% 1.27%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.66% 4.80% 2.86%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.38% 1.18% 1.07%
Unreported/Refused to Report Race and Ethnicity 5.97% 3.94% 3.96%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 37.50%
1 to 24 Hours 21.88%
More Than 24 Hours 40.62%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 6.25%
Staffing to administer the vaccine 46.88%
Vaccine confidence 34.38%
Vaccine storage capacity 0.00%
Vaccine supply 3.12%
Other 12.50%
None 18.75%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 12.50%
Average Percent of Health Center Visits Conducted Virtually 18.44%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 18.75%
Number of Mobile Van Sites 9
Number of Pop-up Clinics 1
Number of School-Based Vaccination Sites 7
Number of Family Vaccination Clinics 17

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 12.50%
Refer patients to another organization that provides monoclonal antibody therapies 62.50%
None 28.12%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 6.25%
Patient awareness/education 3.12%
Staffing capacity 18.75%
Therapy administration/onsite logistics 18.75%
Other 0.00%
None 71.88%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 2
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 8,231

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 50.00%
Provide to General Public Who Came to the Health Center 100.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 100.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022